Although several clinical studies and meta-analyses question the overall patient benefit50–54, careful scrutinization of these studies reveal that fewer patients receiving insulin die from sepsis, but rather die from the complications of inadvertent hypoglycaemia as a result of inadequate glucose control. Here, INS is linked to Sepsis.